Achaogen Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Achaogen is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing antibacterial therapies aimed at multi-drug resistant gram-negative infections. Based in South San Francisco, California, it operates within the biotechnology research industry. The company highlights integrity, accountability, transparency, scientific rigor, and drive as core values and emphasizes a collaborative, scientifically driven work environment. Its products are intended to address unmet medical needs in infectious disease by offering options to healthcare providers and patients dealing with MDR gram-negative infections. A notable development in 2020 was the launch of an antibiotic targeting difficult-to-treat urinary tract infections. The firm positions itself within the late-stage biotechnology space focused on antibacterial agents to combat resistant pathogens.